Symptoms in advanced pancreatic cancer are of importance for energy intake

Supportive Care in Cancer

Volumn 21, Issue 1, 2013, Pages 219-227

  Bye, Asta ^a,b   Jordhøy, Marit S ^a,c   Skjegstad, Grete ^b   Ledsaak, Oddlaug ^b   Iversen, Per Ole ^a,d   Hjermstad, Marianne Jensen ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c INNLANDET HOSPITAL TRUST   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Food intake; Pancreatic cancer; Symptoms; Weight loss

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CALORIC INTAKE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; EARLY INTERVENTION; EATING HABIT; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MALE; PANCREAS CANCER; PANCREAS RESECTION; PATIENT ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SYMPTOM; WEIGHT REDUCTION; XEROSTOMIA;

AGED; AGED, 80 AND OVER; CACHEXIA; DIET; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYMPTOM ASSESSMENT; WEIGHT LOSS;

EID: 84874108544     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1514-8     Document Type: Article

References (45)

1. Wigmore SJ, Plester CE, Richardson RA, Fearon KC (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75(1):106-109
2. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793-799. doi: S0261-5614(08)00113-1 [pii]10.1016/j.clnu.2008.06.013
3. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495
4. Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39-46. doi: 10.1007/s00520-006-0091-0
5. Bovio G, Bettaglio R, Bonetti G, Miotti D, Verni P (2008) Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol 54(3):243-250
6. Bosaeus I, Daneryd P, Svanberg E, Lundholm K (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93(3):380-383. doi: 10.1002/ijc.1332 [pii]
7. Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.1016/j.critrevonc.2010.10.004
8. Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531-1541. doi: 10.1007/s00520-009-0623-5
9. Labori KJ, Hjermstad MJ, Wester T, Buanes T, Loge JH (2006) Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer 14(11):1126-1133. doi: 10.1007/s00520-006-0067-0
10. Damerla V, Gotlieb V, Larson H, Saif MW (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393-396
11. Perez MM, Newcomer AD, Moertel CG, Go VL, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52(2):346-352
12. Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189-2198
13. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24(21):3401-3407. doi: 24/21/3401 [pii] 10.1200/JCO.2005.04.5724
14. Bauer JD, Ash S, Davidson WL, Hill JM, Brown T, Isenring EA, Reeves M (2006) Evidence based practice guidelines for the nutritional management of cancer cachexia. Nutr Diet 63:S3-S32. doi: 10.1111/j.1747-0080.2006.00099.x
15. Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi: 10.1007/s00520-010-1011-x
16. Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo]
17. Lillegaard IT, Overby NC, Andersen LF (2005) Can children and adolescents use photographs of food to estimate portion sizes? Eur J Clin Nutr 59(4):611-617. doi: 1602119 [pii] 10.1038/sj.ejcn.1602119
18. Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, Oslo
19. Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7
20. National food database, version 24/03/2010 (2010) http://www7.slv.se/ livsmedelssok/
21. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6-9
22. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
23. Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939-941
24. Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag 39(2):241-249
25. Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480-487
26. Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17(1):83-90
27. Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, Belgium
28. Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, Hillsdale
29. Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17(10):1317-1324
30. Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New York
31. Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud J-P, Malthiery Y, Simard G, Ritz P (2008) Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 24(5):443-450
32. Bosaeus I (2008) Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16(5):447-451
33. Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi: 10.1007/978-1-84882-118-7-8
34. Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42(1):92-96
35. Sarhill N, Mahmoud F, Walsh D, Nelson KA, Komurcu S, Davis M, LeGrand S, Abdullah O, Rybicki L (2003) Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 11(10):652-659. doi: 10.1007/s00520-003- 0486-0
36. Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27(4):302-310
37. Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377-382
38. Chate A (2006) A pilot audit of weight loss in upper gastrointestinal oncology outpatients. J Hum Nutr Diet 19(6):447-450
39. Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manag 32(4):322-331. doi: S0885-3924(06)00458-1 [pii] 10.1016/j.jpainsymman.2006.05.012
40. Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680-685
41. Sreebny LM, Schwartz SS (1997) A reference guide to drugs and dry mouth - 2nd edition. Gerodontology 14(1):33-47
42. Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11(4):226-231
43. Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156-165. doi: S0885-3924(06)00630-0 [pii]10.1016/j.jpainsymman.2006.07.017
44. Sanchez-Lara K, Sosa-Sanchez R, Green-Renner D, Rodriguez C, Laviano A, Motola-Kuba D, Arrieta O (2010) Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9:15. doi: 1475-2891-9-15 [pii]10.1186/1475-2891-9-15
45. Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152-163